Navigation Links
New Research Discloses that Pseudotumor Formation Occurs in Close to 30% of Metal-on-Metal Hip Implants, Parker Waichman LLP Notes
Date:9/24/2013

New York, New York (PRWEB) September 24, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, reports that, based on new research from a group in The Netherlands, formation of pseudotumors occurs in 28% of metal-on-metal hip implants. As reported on the Sept. 13 edition of the medical news website Healio’s Orthopedics Today, from the period of 2005 through 2010, 129 patients (149 hips) underwent metal-on-metal hip resurfacing surgery with a metal-on-metal femoral head and acetabular shell (four patients ultimately dropped out, however, lowering the study’s final tally to 143 metal hips). After about 41 months, researchers found via CT scans pseudotumors in 39 patients. Seven of them underwent revision surgery because of symptomatic pseudotumors. Ten patients with pseudotumors complained of groin pain, the presence of a noticeable mass or paresthesia (a sensation of tingling, tickling, prickling, pricking, or burning).

“They say knowledge is power, so these findings are helpful for patients with metal-on-metal hip implants,” said Daniel C. Burke, Senior Litigation Counsel at Parker Waichman LLP. “There are numerous lawsuits alleging that an all-metal hip replacement caused pseudotumors, among other serious complications.”

Parker Waichman LLP is currently representing clients in several litigations related to metal-on-metal hip implants, including in multidistrict litigations (MDLs) such as In Re: DePuy Orthopaedics, Inc., ASR Hip Implant Products Liability Litigation (MDL No. 2197) in U.S. District Court, Northern District of Ohio; and In re: Biomet M2a Magnum Hip Implants Products Liability Litigation (MDL No. 2391) in U.S. District Court for the Northern District of Indiana, South Bend Division. Additionally, there is a multicounty litigation (MCL) entitled In Re: Stryker Rejuvenate Hip Stem and ABG II Modular Hip Stem Litigation (MCL No. 296) in New Jersey’s Superior Court of Bergen County.

Metal-on-metal hip devices have been recalled worldwide, as the U.S. Food and Drug Administration (FDA) noted in a Jan. 17, 2013, recall update. The regulator has put the metal-on-metal class of medical devices under increased scrutiny following reports of high failure rates and the release of elevated concentrations of metallic debris into the bloodstream. Also on Jan. 17, the FDA released new guidelines for patients implanted with all-metal devices. The agency advised they get:

  •     Regular physical examinations,
  •     Diagnostic imaging, and
  •     Metal ion testing conducted in symptomatic patients.

Additionally, new data from Canada suggests that people implanted with metal-on-metal hips are likelier to require revision surgery within five years of the procedure, according to a July 18 CBC News report. The Canadian Institutes for Health Information report revealed that people with metal-on-metal implants face a 5.9 percent increased likelihood of needing a device replacement within five years of the original implantation; this compares with a 2.7 percent rate among people who received metal-on-plastic implants. The all-metal implant design did not work as expected, CBC News reported. In fact, under the body’s weight during daily activity—such as simply walking—the implant’s metal parts rub against each other. This chafing causes metal particles to shed into the person’s surrounding tissue and bloodstream, causing bone and tissue damage due to metallosis (metal poisoning), as well as pseudotumors and the need for early revision surgery to remove and replace the hip device.

Parker Waichman LLP continues to offer free legal consultations to victims of injuries allegedly caused by metal-on-metal hip implants. If you or a loved one have experienced premature failure of, or other health problems associated with, a metal-on-metal hip implant, please contact their office by visiting the firm's Defective Hip Implant page at yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/pseudotumor_study_implant/09/prweb11158529.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
5. Sexually abused boys at risk for more unsafe sex: UBC research
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
8. Researchers find evidence of banned antibiotics in poultry products
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. Scientific session and new research highlights
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... “We are thrilled to be partnering with ... to schedule an appointment online in real time,” said Keith English, LocalMed CEO. “Allowing ... directory will bring more Six Month Smiles patients to their providers.” , Each month, ...
(Date:7/26/2017)... ... July 26, 2017 , ... Isodiol ... global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces ... 2017 to June 30, 2017. Iso International LLC recorded unaudited fiscal Q1 profits ...
(Date:7/26/2017)... ... 26, 2017 , ... BioPlus Specialty Pharmacy (BioPlus), ... of the HCV Treatment Path app (version 4.4.0) to keep health care providers ... All of the latest HCV medications are included in this app, including Vosevi™ ...
(Date:7/25/2017)... , ... July 25, 2017 , ... Summers in Palm ... the air conditioner — think homemade gourmet ice cream, sparkling pools, and mile-high fun. ... shop featuring fun mugs, journals, and other must-have knick knacks. Ice cream and sorbet ...
(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance ... services to communities across North Carolina, is launching a charity event in conjunction ... support for the ongoing fight against bladder cancer. , The Bladder Cancer Advocacy ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... IBM (NYSE: IBM ) has been recognized as a ... for the fourth year in a row. 1 ... the Leaders quadrant have the highest scores for their Ability ... Leaders quadrant has the market share, credibility, and marketing and ... These vendors demonstrate a clear understanding of market needs; they ...
(Date:7/21/2017)... and RESEARCH TRIANGLE PARK, N.C. ... Corporation (NASDAQ: UTHR ) announced today that ... before the market opens on Thursday, July 27, 2017. ... host a teleconference on Thursday, July 27, 2017, at ... dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast ...
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) released ... , M.D., following today,s Institute for Clinical and Economic Review,s ... on the effectiveness and value of abuse-deterrent formulations (ADF) of ... policy roundtable at the meeting. ... material cost benefit to the use of abuse-deterrent formulations (ADF) ...
Breaking Medicine Technology: